Darrin Kuijstermans, MsC, PhD Lonza

Darrin Kuijstermans has over 20+ years of experience in bioprocess development that includes his work at Lonza in the Cell and Gene Therapy (CGT) space. His background spans both the biologics and cell and gene therapy development and manufacturing industries gaining experience in managing development projects in bioreactor based processes, process analytical technologies and quality by design. Dr. Kuijstermans joined Lonza in Q1 2018 and lead the build-out of the cell therapy process development labs at their Houston site, at the time the world’s largest dedicated cell and gene therapies (CGT) manufacturing facility, now a commercial cell and gene therapy manufacturing site. As the Associate Director of Process Development, he leads multiple development projects focused on platforms and services centered around allogeneic and autologous applications. His experience in Cell & Gene Therapy space covers all facets involved in the development of cGMP manufacturing processes from phase I to commercial readiness implementation.